These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dynamics of Zn(II) binding as a key feature in the formation of amyloid fibrils by Aβ11-28. Alies B; Solari PL; Hureau C; Faller P Inorg Chem; 2012 Jan; 51(1):701-8. PubMed ID: 22148916 [TBL] [Abstract][Full Text] [Related]
23. Methods for structural characterization of prefibrillar intermediates and amyloid fibrils. Langkilde AE; Vestergaard B FEBS Lett; 2009 Aug; 583(16):2600-9. PubMed ID: 19481541 [TBL] [Abstract][Full Text] [Related]
24. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice. Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277 [TBL] [Abstract][Full Text] [Related]
25. An amyloid-like fibril-forming supramolecular cross-β-structure of a model peptide: a crystallographic insight. Maity S; Kumar P; Haldar D Org Biomol Chem; 2011 May; 9(10):3787-91. PubMed ID: 21448469 [TBL] [Abstract][Full Text] [Related]
26. Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family. Iconomidou VA; Chryssikos GD; Gionis V; Galanis AS; Cordopatis P; Hoenger A; Hamodrakas SJ J Struct Biol; 2006 Dec; 156(3):480-8. PubMed ID: 17056273 [TBL] [Abstract][Full Text] [Related]
27. Methods for Structural Analysis of Amyloid Fibrils in Misfolding Diseases. Vadukul DM; Al-Hilaly YK; Serpell LC Methods Mol Biol; 2019; 1873():109-122. PubMed ID: 30341606 [TBL] [Abstract][Full Text] [Related]
28. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784 [TBL] [Abstract][Full Text] [Related]
34. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287 [TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationship of amyloid fibrils. Maji SK; Wang L; Greenwald J; Riek R FEBS Lett; 2009 Aug; 583(16):2610-7. PubMed ID: 19596006 [TBL] [Abstract][Full Text] [Related]
36. X-ray scattering study of the effect of hydration on the cross-beta structure of amyloid fibrils. Squires AM; Devlin GL; Gras SL; Tickler AK; MacPhee CE; Dobson CM J Am Chem Soc; 2006 Sep; 128(36):11738-9. PubMed ID: 16953596 [TBL] [Abstract][Full Text] [Related]
37. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states. Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543 [TBL] [Abstract][Full Text] [Related]